Fisher Katlin

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen

J. Garber, T. King, L. Pace, 2022, Breast Cancer Research and Treatment.

Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS

S. Schnitt, T. King, F. Nakhlis, 2022, Annals of Surgical Oncology.